JGGDR
JGP Global Gestao de Recursos Portfolio holdings
AUM
$204M
This Quarter Return
-3.28%
1 Year Return
+109.69%
3 Year Return
+285.93%
5 Year Return
+345.7%
10 Year Return
+378.07%
AUM
$158M
AUM Growth
+$158M
(+12%)
Cap. Flow
+$21.2M
Cap. Flow
% of AUM
13.44%
Top 10 Holdings %
Top 10 Hldgs %
86.37%
Holding
70
New
10
Increased
4
Reduced
30
Closed
19
Top Buys
| 1 |
Mercado Libre
MELI
|
$18.1M |
| 2 |
StoneCo
STNE
|
$16.6M |
| 3 |
Sigma Lithium
SGML
|
$13.1M |
| 4 |
Nu Holdings
NU
|
$9.56M |
| 5 |
Jacobs Solutions
J
|
$271K |
Top Sells
| 1 |
XP
XP
|
$24.4M |
| 2 |
ATVI
Activision Blizzard Inc.
ATVI
|
$6.04M |
| 3 |
Microsoft
MSFT
|
$5.62M |
| 4 |
NVIDIA
NVDA
|
$4.59M |
| 5 |
Alphabet (Google) Class C
GOOG
|
$1.83M |
Sector Composition
| 1 | Financials | 24.19% |
| 2 | Technology | 13.69% |
| 3 | Consumer Discretionary | 12.02% |
| 4 | Healthcare | 11.46% |
| 5 | Materials | 11.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
XP
XP
$9.56B
| $26M | 16.43% |
1,126,913
-1,060,192
| -48% | -$24.4M |
|
|
2
Mercado Libre
MELI
$125B
| $18.9M | 11.98% |
14,939
+14,279
| +2,163% | +$18.1M |
|
|
3
Sigma Lithium
SGML
$747M
| $18M | 11.38% |
554,610
+405,240
| +271% | +$13.1M |
|
|
4
StoneCo
STNE
$4.41B
| $16.6M | 10.5% |
+1,556,011
| New | +$16.6M |
|
|
5
Nu Holdings
NU
$71.5B
| $11.4M | 7.21% |
1,571,587
+1,318,887
| +522% | +$9.56M |
|
|
ATVI
6
DELISTED
Activision Blizzard Inc.
ATVI
| $4.96M | 3.14% |
53,000
-64,500
| -55% | -$6.04M |
|
|
SGEN
7
DELISTED
Seagen Inc. Common Stock
SGEN
| $3.73M | 2.36% |
17,598
-6
| -0% | -$1.27K |
|
8
UnitedHealth
UNH
$281B
| $1.58M | 1% |
3,136
-34
| -1% | -$17.1K |
|
9
Eli Lilly
LLY
$657B
| $1.26M | 0.8% |
2,346
-1,025
| -30% | -$551K |
|
10
Thermo Fisher Scientific
TMO
$186B
| $951K | 0.6% |
1,879
-20
| -1% | -$10.1K |
|
|
ONC
11
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
| $752K | 0.48% |
4,180
-2
| -0% | -$360 |
|
12
Incyte
INCY
$16.5B
| $720K | 0.46% |
12,457
-12
| -0.1% | -$693 |
|
13
Danaher
DHR
$147B
| $702K | 0.44% |
2,828
-31
| -1% | -$7.69K |
|
14
VanEck Gold Miners ETF
GDX
$19B
| $688K | 0.44% |
25,583
| – | – |
|
15
Regeneron Pharmaceuticals
REGN
$61.5B
| $674K | 0.43% |
819
-8
| -1% | -$6.58K |
|
16
AstraZeneca
AZN
$248B
| $663K | 0.42% |
9,797
-106
| -1% | -$7.18K |
|
17
Merck
MRK
$210B
| $638K | 0.4% |
6,195
-67
| -1% | -$6.9K |
|
18
Intuitive Surgical
ISRG
$170B
| $629K | 0.4% |
2,153
-23
| -1% | -$6.72K |
|
19
argenx
ARGX
$43.6B
| $627K | 0.4% |
1,275
-10
| -0.8% | -$4.92K |
|
20
Vertex Pharmaceuticals
VRTX
$100B
| $521K | 0.33% |
1,497
-16
| -1% | -$5.56K |
|
21
Elevance Health
ELV
$71.8B
| $519K | 0.33% |
1,193
-13
| -1% | -$5.66K |
|
22
Stryker
SYK
$150B
| $495K | 0.31% |
1,810
-19
| -1% | -$5.19K |
|
23
Humana
HUM
$36.5B
| $405K | 0.26% |
833
-8
| -1% | -$3.89K |
|
24
Becton Dickinson
BDX
$55.3B
| $358K | 0.23% |
1,383
-15
| -1% | -$3.88K |
|
25
Acadia Pharmaceuticals
ACAD
$4.38B
| $341K | 0.22% |
16,353
-15
| -0.1% | -$313 |
|